430 related articles for article (PubMed ID: 32766313)
61. Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
Jia R; Weng Y; Li Z; Liang W; Ji Y; Liang Y; Ning P
Reprod Sci; 2021 Aug; 28(8):2331-2341. PubMed ID: 33650093
[TBL] [Abstract][Full Text] [Related]
62. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
63. Identification of Subtypes in Triple-negative Breast Cancer Based on Shared Genes Between Immunity and Cancer Stemness.
Lv X; Lan G; Guo Q
J Immunother; 2024 May; 47(4):107-116. PubMed ID: 38369822
[TBL] [Abstract][Full Text] [Related]
64. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
[TBL] [Abstract][Full Text] [Related]
65. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
[TBL] [Abstract][Full Text] [Related]
66. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
Feng J; Li Y; Wen N
Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
[TBL] [Abstract][Full Text] [Related]
67. Identification of key genes associated with cancer stem cell characteristics in Wilms' tumor based on bioinformatics analysis.
Su C; Zheng J; Chen S; Tuo J; Su J; Ou X; Chen S; Wang C
Ann Transl Med; 2022 Nov; 10(22):1204. PubMed ID: 36544656
[TBL] [Abstract][Full Text] [Related]
68. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
69. Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes.
Kalecky K; Modisette R; Pena S; Cho YR; Taube J
BMC Cancer; 2020 Feb; 20(1):141. PubMed ID: 32085745
[TBL] [Abstract][Full Text] [Related]
70. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
[TBL] [Abstract][Full Text] [Related]
71. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
[TBL] [Abstract][Full Text] [Related]
72. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
Zhao X; Lin J
Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
[TBL] [Abstract][Full Text] [Related]
73. Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24-/low) indicate poor prognosis in triple-negative breast cancer.
Chang SJ; Ou-Yang F; Tu HP; Lin CH; Huang SH; Kostoro J; Hou MF; Chai CY; Kwan AL
Hum Pathol; 2016 Feb; 48():48-55. PubMed ID: 26772398
[TBL] [Abstract][Full Text] [Related]
74. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S
J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274
[TBL] [Abstract][Full Text] [Related]
75. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.
Huang Y; Wang X; Zheng Y; Chen W; Zheng Y; Li G; Lou W; Wang X
Aging (Albany NY); 2021 Jan; 13(1):1153-1175. PubMed ID: 33428596
[TBL] [Abstract][Full Text] [Related]
76. BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.
Cai P; Lu Z; Wu J; Qin X; Wang Z; Zhang Z; Zheng L; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2643-2654. PubMed ID: 31692043
[TBL] [Abstract][Full Text] [Related]
77. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
Wang XC; Liu Y; Long FW; Liu LR; Fan CW
Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362
[TBL] [Abstract][Full Text] [Related]
78. HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration.
Ying B; Xu W; Nie Y; Li Y
Dis Markers; 2022; 2022():8446857. PubMed ID: 36452344
[TBL] [Abstract][Full Text] [Related]
79. Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy.
Zhou Y; Che Y; Fu Z; Zhang H; Wu H
Front Public Health; 2022; 10():902378. PubMed ID: 35875026
[TBL] [Abstract][Full Text] [Related]
80. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]